Overview
Molecular Biomedicine, published by Springer Nature (Singapore), published 366 papers in 2021–2025, and its papers received 9,220 citations in those years. Its h-index is 54 and its two-year mean citedness is 11.17. On the ITS Journal Score it ranks #2,195 of 62,158 ranked journals and #269 of 1,066 in Biochemistry, Genetics and Molecular Biology.
Key figures
Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.
Papers and citations by year
| Year | Papers | Citations received | Open-access papers |
|---|---|---|---|
| 2020 | 19 | 616 | 19 |
| 2021 | 41 | 1,352 | 41 |
| 2022 | 48 | 2,248 | 48 |
| 2023 | 50 | 1,547 | 50 |
| 2024 | 74 | 1,708 | 74 |
| 2025 | 153 | 2,365 | 153 |
What it publishes
The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.
Similar journals
Ranked journals that publish on the same topics.
| Journal | Field | Score | Papers 2021–2025 | Open access |
|---|---|---|---|---|
| Clinical Epigenetics | Biochemistry, Genetics and Molecular Biology | 81.1 | 1,053 | 100% |
| Epigenetics | Biochemistry, Genetics and Molecular Biology | 77.8 | 441 | 100% |
| Epigenomics | Biochemistry, Genetics and Molecular Biology | 74.6 | 603 | 56% |
| Epigenomes | Biochemistry, Genetics and Molecular Biology | 67.0 | 203 | 100% |
| MedComm | Medicine | 84.5 | 1,315 | 100% |
| Epigenetics Insights | Biochemistry, Genetics and Molecular Biology | 53.7 | 50 | 100% |
| Cell Discovery | Biochemistry, Genetics and Molecular Biology | 85.9 | 623 | 100% |
| Frontiers in Bioscience-Landmark | Biochemistry, Genetics and Molecular Biology | 75.4 | 1,667 | 100% |
Compare with similar journals (side by side with the two closest journals above)
Identity and sources
- ISSN-L: 2662-8651
- Print ISSN: 2662-8651
- Publisher: Springer Nature
- Listed in DOAJ: Yes (checked against DOAJ)
- Crossref: Not yet checked
- OpenAlex: S4210227457
- Journal website: www.springer.com
Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.
Questions
What is the ITS Journal Score of Molecular Biomedicine?
It is 79.9 out of 100, which places it #2,195 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.
What is the impact factor of Molecular Biomedicine?
This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 11.17.
Is Molecular Biomedicine open access?
100% of its papers from 2021–2025 are recorded as open access, and it is listed in DOAJ.
Does Molecular Biomedicine charge a publication fee?
DOAJ records an article processing charge of 2,490 EUR. Check the journal's website for the current fee and any waivers.